Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1038/S41386-020-00838-X | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
We aimed to develop and validate classification models able to identify individuals at high risk for transition from a diagnosis of depressive disorder to one of bipolar disorder. This retrospective health records cohort study applied outpatient clinical data from psychiatry and nonpsychiatry practice networks affiliated with two large academic medical centers between March 2008 and December 2017. Participants included 67,807 individuals with a diagnosis of major depressive disorder or depressive disorder not otherwise specified and no prior diagnosis of bipolar disorder, who received at least one of the nine antidepressant medications. The main outcome was at least one diagnostic code reflective of a bipolar disorder diagnosis within 3 months of index antidepressant prescription. Logistic regression and random forests using diagnostic and procedure codes as well as sociodemographic features were used to predict this outcome, with discrimination and calibration assessed in a held-out test set and then a second academic medical center. Among 67,807 individuals who received at least one antidepressant medication, 925 (1.36%) subsequently received a diagnosis of bipolar disorder within 3 months. Models incorporating coded diagnoses and procedures yielded a mean area under the receiver operating characteristic curve of 0.76 (ranging from 0.73 to 0.80). Standard supervised machine learning methods enabled development of discriminative and transferable models to predict transition to bipolar disorder. With further validation, these scores may enable physicians to more precisely calibrate follow-up intensity for high-risk patients after antidepressant initiation.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Pradier, Melanie F. | Mujer |
Harvard John A. Paulson School of Engineering and Applied Sciences - Estados Unidos
Harvard A John Paulson Sch Engn & Appl Sci - Estados Unidos |
| 2 | Hughes, Michael C. | Hombre |
Tufts University - Estados Unidos
Tufts Univ - Estados Unidos |
| 3 | McCoy, Thomas H. | Hombre |
Massachusetts General Hospital - Estados Unidos
Harvard Medical School - Estados Unidos MASSACHUSETTS GEN HOSP - Estados Unidos Harvard Med Sch - Estados Unidos |
| 4 | BARROILHET-DIEZ, SERGIO ANDRES | Hombre |
Massachusetts General Hospital - Estados Unidos
Harvard Medical School - Estados Unidos Tufts University School of Medicine - Estados Unidos Hospital Clínico de la Universidad de Chile - Chile MASSACHUSETTS GEN HOSP - Estados Unidos Harvard Med Sch - Estados Unidos Tufts Univ - Estados Unidos Universidad de Chile - Chile Hospital Clínico Universidad de Chile - Chile |
| 5 | Doshi-Velez, Finale | - |
Harvard John A. Paulson School of Engineering and Applied Sciences - Estados Unidos
Harvard A John Paulson Sch Engn & Appl Sci - Estados Unidos |
| 6 | Perlis, Roy H. | Hombre |
Massachusetts General Hospital - Estados Unidos
Harvard Medical School - Estados Unidos MASSACHUSETTS GEN HOSP - Estados Unidos Harvard Med Sch - Estados Unidos |
| Fuente |
|---|
| National Heart, Lung, and Blood Institute |
| National Institute of Mental Health |
| National Human Genome Research Institute |
| National Institute on Aging |
| NHLBI |
| NIMH |
| Brain and Behavior Research Foundation |
| Harvard Data Science Initiative |
| Harvard |
| National Institute of Aging |
| Stanley Center for Psychiatric Research, Broad Institute |
| Broad Institute |
| Telefonica Alfa |
| NHGRI |
| Harvard SEAS |
| Oracle Labs |
| Stanley Center at the Broad Institute |
| Department of Communications, Energy and Natural Resources, Ireland |
| Oracle |
| Agradecimiento |
|---|
| This work was funded by Oracle Labs, Harvard SEAS, the Harvard Data Science Initiative, and a grant from the National Institute of Mental Health (grant no. 1R01MH106577). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. RHP holds equity in Psy Therapeutics and Outermost Therapeutics; serves on the scientific advisory boards of Genomind and Takeda; and consults to RID Ventures. RHP receives research funding from NIMH, NHLBI, NHGRI, and Telefonica Alfa. RHP is an associate editor for JAMA Network Open. THM receives research funding from the Stanley Center at the Broad Institute, the Brain and Behavior Research Foundation, National Institute of Aging, and Telefonica Alfa. FDV consults for Davita Kidney Care and Google Health. The other authors have no disclosures to report. |
| This work was funded by Oracle Labs, Harvard SEAS, the Harvard Data Science Initiative, and a grant from the National Institute of Mental Health (grant no. 1R01MH106577). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. RHP holds equity in Psy Therapeutics and Outermost Therapeutics; serves on the scientific advisory boards of Genomind and Takeda; and consults to RID Ventures. RHP receives research funding from NIMH, NHLBI, NHGRI, and Telefonica Alfa. RHP is an associate editor for JAMA Network Open. THM receives research funding from the Stanley Center at the Broad Institute, the Brain and Behavior Research Foundation, National Institute of Aging, and Telefonica Alfa. FDV consults for Davita Kidney Care and Google Health. The other authors have no disclosures to report. |